Rasheed Ghany

Summary

Rasheed Ghany. Role: unknown. No source read in this review states the role of this author. Field: unknown. Affiliation: unknown (marked missing). Basis: unverified; OpenAlex lists "University Health Network" on the most recent corpus paper (2026). Not confirmed as current.. Counts in the OpenAlex corpus (retrieved 2026-10-10): 47 papers and 360 citations over ten years; 0 first-author and 0 last-author papers. Ranks: main 95, excluding consensus papers 82, first or last author not ranked. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.

Citation ranks (10 years)

Citations: 360 in total, 360 excluding consensus and guideline papers (0 of this author's papers excluded), 0 on first or last author papers (0 first, 0 last).

Role and field

Role

unknown

Role status

unknown (no source read in this review states the role)

Field

unknown

Field basis

no unit name found in the sources read

Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.

Details

papers 10y

47

fractional papers 10y

3.83

citations 10y

360

fractional citations 10y

27

rising rank 5y

16 of 25

ranking retrieved

2026-10-10

orcid

0000-0002-2526-5107

openalex author id

A5057289348

merged open alex profiles

2

affiliation basis

unverified; OpenAlex lists "University Health Network" on the most recent corpus paper (2026). Not confirmed as current.

papers excluding consensus 10y

47

citations excluding consensus 10y

360

consensus papers excluded 10y

0

first author papers 10y

0

last author papers 10y

0

lead author citations 10y

0

lead author papers 10y

0

Sources and links

• ORCID record (primary)
• OpenAlex author profile (ranking source)
• Most-cited CLAD paper in corpus: Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system (The Journal of Heart and Lung Transplantation, 2020); 77 citations; DOI 10.1016/j.healun.2020.04.012
• Most-cited CLAD paper in corpus: The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation (American Journal of Transplantation, 2020); 51 citations; DOI 10.1111/ajt.15561
• Most-cited CLAD paper in corpus: Significance of phenotype change after chronic lung allograft dysfunction onset (Transplant International, 2021); 12 citations; DOI 10.1111/tri.14157
• Most-cited CLAD paper in corpus: Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction (The Journal of Heart and Lung Transplantation, 2024); 10 citations; DOI 10.1016/j.healun.2024.01.002
• Most-cited CLAD paper in corpus: Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction (The Journal of Heart and Lung Transplantation, 2023); 10 citations; DOI 10.1016/j.healun.2023.03.009

Related

Links from this record

• author: Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system
• author: The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation.
• author: Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction
• author: Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction

Known gaps in this record

• role or job title
• centre membership relation (not asserted)
• funding and conflicts of interest
• verified current affiliation
• only the top-30 entries were checked by hand for ID merges and splits